File Download

There are no files associated with this item.

  Links for fulltext
     (May Require Subscription)
Supplementary

Article: Understanding China’s shifting priorities and priority-setting processes in development assistance for health

TitleUnderstanding China’s shifting priorities and priority-setting processes in development assistance for health
Authors
KeywordsChina
health systems research
infectious diseases
malaria
ophthalmology
overseas development assistance
politics
Issue Date1-Jan-2024
PublisherOxford University Press
Citation
Health Policy and Planning, 2024, v. 39, p. i65-i78 How to Cite?
AbstractOver the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of Chinese DAH and compare them to comparable trends among OECD Development Assistance Committee (DAC) donors using data from the AidData’s Global Chinese Development Finance Dataset (2000–2017, version 2.0) and the Creditor Reporting System (CRS) database (2000–2017). We also analyse Chinese medical aid exports before and after the start of the COVID-19 pandemic using a Chinese Aid Exports Database. We further explore the potential factors influencing China’s shifting priority-setting processes by reviewing Chinese official documents following Walt and Gilson’s policy analysis framework (context–actors–process–content) and by testing our conjectures empirically. We find that China has become an important DAH donor to most regions if measured using project value, including but not limited to Africa. China has prioritized aid to African and Asian countries as well as to CRS subsectors that are not prioritized by DAC donors, such as medical services and basic health infrastructure. Chinese quarterly medical aid exports almost quintupled after the start of the COVID-19 pandemic. Noticeably, China has allocated more attention to Asia, eye diseases and infectious disease outbreaks over time. In contrast, the priority given to malaria has declined over the same period. Regarding factors affecting priority shifts, the outbreaks of SARS and Ebola, the launch of the Belt and Road Initiative and the COVID-19 pandemic appear to be important milestones in the timeline of Chinese DAH. Unlike stereotypes of China as a ‘lone wolf’ donor, our analysis suggests multilateral processes are influential in informing and setting Chinese DAH priorities.
Persistent Identifierhttp://hdl.handle.net/10722/345868
ISSN
2023 Impact Factor: 2.9
2023 SCImago Journal Rankings: 1.302

 

DC FieldValueLanguage
dc.contributor.authorGuo, Bingqing-
dc.contributor.authorFan, Victoria-
dc.contributor.authorStrange, Austin-
dc.contributor.authorGrépin, Karen Ann-
dc.date.accessioned2024-09-04T07:06:04Z-
dc.date.available2024-09-04T07:06:04Z-
dc.date.issued2024-01-01-
dc.identifier.citationHealth Policy and Planning, 2024, v. 39, p. i65-i78-
dc.identifier.issn0268-1080-
dc.identifier.urihttp://hdl.handle.net/10722/345868-
dc.description.abstractOver the past two decades, China has become a distinctive and increasingly important donor of development assistance for health (DAH). However, little is known about what factors influence China’s priority-setting for DAH. In this study, we provide an updated analysis of trends in the priorities of Chinese DAH and compare them to comparable trends among OECD Development Assistance Committee (DAC) donors using data from the AidData’s Global Chinese Development Finance Dataset (2000–2017, version 2.0) and the Creditor Reporting System (CRS) database (2000–2017). We also analyse Chinese medical aid exports before and after the start of the COVID-19 pandemic using a Chinese Aid Exports Database. We further explore the potential factors influencing China’s shifting priority-setting processes by reviewing Chinese official documents following Walt and Gilson’s policy analysis framework (context–actors–process–content) and by testing our conjectures empirically. We find that China has become an important DAH donor to most regions if measured using project value, including but not limited to Africa. China has prioritized aid to African and Asian countries as well as to CRS subsectors that are not prioritized by DAC donors, such as medical services and basic health infrastructure. Chinese quarterly medical aid exports almost quintupled after the start of the COVID-19 pandemic. Noticeably, China has allocated more attention to Asia, eye diseases and infectious disease outbreaks over time. In contrast, the priority given to malaria has declined over the same period. Regarding factors affecting priority shifts, the outbreaks of SARS and Ebola, the launch of the Belt and Road Initiative and the COVID-19 pandemic appear to be important milestones in the timeline of Chinese DAH. Unlike stereotypes of China as a ‘lone wolf’ donor, our analysis suggests multilateral processes are influential in informing and setting Chinese DAH priorities.-
dc.languageeng-
dc.publisherOxford University Press-
dc.relation.ispartofHealth Policy and Planning-
dc.rightsThis work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.-
dc.subjectChina-
dc.subjecthealth systems research-
dc.subjectinfectious diseases-
dc.subjectmalaria-
dc.subjectophthalmology-
dc.subjectoverseas development assistance-
dc.subjectpolitics-
dc.titleUnderstanding China’s shifting priorities and priority-setting processes in development assistance for health-
dc.typeArticle-
dc.identifier.doi10.1093/heapol/czad095-
dc.identifier.pmid38253445-
dc.identifier.scopuseid_2-s2.0-85183125222-
dc.identifier.volume39-
dc.identifier.spagei65-
dc.identifier.epagei78-
dc.identifier.eissn1460-2237-
dc.identifier.issnl0268-1080-

Export via OAI-PMH Interface in XML Formats


OR


Export to Other Non-XML Formats